DASH
Repository logo
Communities & Collections
Browse DASH
DASH Stories
Statistics
  1. Home
  2. Faculty of Arts and Sciences
  3. FAS Theses and Dissertations
  4. Diet, Metabolomics, and Parkinson's Disease

Diet, Metabolomics, and Parkinson's Disease

Open/View files
MOLSBERRY-DISSERTATION-2019.pdf (3.22 MB)
Date
May 6, 2019
Author(s)
Molsberry, Samantha
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Molsberry, Samantha. 2019. Diet, Metabolomics, and Parkinson's Disease. Doctoral dissertation, Harvard University, Graduate School of Arts & Sciences.
Abstract
Parkinson’s disease (PD) is a progressive neurodegenerative disease that affects motor control and is characterized by several hallmark symptoms, including resting tremor, bradykinesia, rigidity, and postural instability. Existing treatments are unable to stop or slow the progression of PD. The lack of effective treatment is likely due in part to the fact that PD develops insidiously over an extended period such that there is already extensive and irreversible neurodegeneration by the time of clinical diagnosis. In order to deliver treatment before neurodegeneration is too extensive, it is therefore vital to better understand and reliably recognize the prodromal phase of PD. In Chapter 1, we used blood samples from 349 matched case-control pairs in the Nurses’ Health Study (NHS) and the Health Professionals Follow-up Study (HPFS) to examine whether metabolites known to be associated with insulin resistance and diabetes were also associated with the development of PD. In these analyses, there was no evidence that these markers of insulin resistance and diabetes were associated with PD, corroborating previous research in these cohorts that failed to identify a relationship between diabetes and PD. In Chapter 2, we used blood samples from 817 matched case-control pairs in the NHS, the HPFS, and the Cancer Prevention Study II Nutrition Survey Cohort (CPS-IIN) to investigate whether pre-diagnostic plasma metabolite levels could act as risk factors for or biomarkers of PD. Several metabolites were nominally associated with PD but, after adjustment for multiple testing, none remained significant. Further, we were unable to reliably distinguish cases from controls based on their metabolomic profiles. These results contradict several retrospective metabolomics investigations of PD and emphasize the need for careful study design in investigations of potential biomarkers. In Chapter 3, we assessed whether adherence to a Mediterranean-style diet was associated with non-motor features of prodromal PD. Here, we found that increased adherence to a Mediterranean-style diet was associated with a lower combined number of prodromal Parkinson’s features as well as with three specific features. These findings add further weight to the evidence that adherence to a Mediterranean-style diet could reduce the occurrence of specific features of prodromal Parkinson’s disease.
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service
URI
http://nrs.harvard.edu/urn-3:HUL.InstRepos:42029734
Subjects

Diet

metabolomics

Parkinson's disease

epidemiology

Collection
FAS Theses and Dissertations
Metrics
Repository logo
  • CONTACT US
  • OSRDS
  • ABOUT DASH
  • DEPOSITING TO DASH
  • TERMS OF USE
  • REQUEST A WAIVER
  • TAKE DOWN POLICY
  • NAME CHANGE POLICY
  • HARVARD OA POLICIES
  • DASH SUBMITTER AGREEMENT
  • Accessibility
  • Privacy
Creative Commons License BY
Creative Commons Attribution 4.0 International License

Except where otherwise noted, this work is subject to a Creative Commons Attribution 4.0 International License,
which allows anyone to share and adapt our material as long as proper attribution is given.
For details and exceptions, see the Harvard Library Copyright Policy
©2024 Presidents and Fellows of Harvard College.